Trials / Completed
CompletedNCT02382809
Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction
Efficacy of DC071 Mouthwash (0.2% Chlorhexidine Digluconate) in Peri-surgical Care for Preventing Alveolar Osteitis After Third Molar Extraction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 414 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the efficacy of 0.2 % digluconate chlorhexidine mouthwash in the prevention of alveolar osteitis following third molar extraction and to evaluate the safety and local tolerability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DC071 | Mouthwash, twice daily |
| DRUG | Placebo | Mouthwash, twice daily |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2015-03-09
- Last updated
- 2016-03-09
Locations
18 sites across 4 countries: Estonia, France, Latvia, Lithuania
Source: ClinicalTrials.gov record NCT02382809. Inclusion in this directory is not an endorsement.